| U.s. Medical eligibility criteria for contraceptive use, 2010. | |
| | |
MedLine Citation:
|
PMID: 21671772 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Abstract Women with unintended pregnancies are more likely to experience poor pregnancy outcomes. For women with medical conditions, unintended pregnancy may worsen the condition and carry even greater risk of adverse pregnancy outcomes, including maternal and perinatal death. Although safe and highly effective contraceptive methods are available to prevent unintended pregnancy, there may be concerns about the safety of contraceptive methods among women with medical conditions. The Centers for Disease Control and Prevention (CDC) has recently developed the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010, which provides evidence-based recommendations for the safety of contraceptive use among women with medical conditions. Most women, even those with medical conditions, can safely use most methods of contraception. |
| | |
Authors:
|
Kathryn M Curtis; Naomi K Tepper; Polly A Marchbanks |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of women's health (2002) Volume: 20 ISSN: 1931-843X ISO Abbreviation: J Womens Health (Larchmt) Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-06-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101159262 Medline TA: J Womens Health (Larchmt) Country: United States |
Other Details:
|
Languages: eng Pagination: 825-8 Citation Subset: IM |
Affiliation:
|
Division of Reproductive Health, Centers for Disease Control and Prevention , Atlanta, Georgia . |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: EXPRESSION OF HYPOXIA INDUCIBLE FACTOR, ITS REGULATORY AND TARGET GENES IN CONGENITAL DIAPHRAGMATIC ...
Next Document: After inclusion, information and inference: reporting on clinical trials results after 15 years of m...